OR4K7P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, OR4K7P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR4K7P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher OR4K7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4K7P expression acts as an unfavorable survival marker.

LUSC, SKCM, and THCA are the cancer types where OR4K7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUSCOSTertileII,III,IV0.2020.635.00254view →
SKCMOSTertileAll0.5530.874<.00148view →
THCADFSTertileII,III,IV0.1450.794.00139view →
KIRCDFSTertileIV0.0390.632<.00118view →
OVOSTertileIV0.2530.633.03718view →
ESCAOSTertileII,III,IV0.1050.867.01618view →
KIRPOSTertileAll0.1690.708.00115view →
PAADDFSTertileII,III,IV0.0760.474.0019view →
KICHOSTertileAll0.8310.992.0149view →
READDFSTertileIII,IV0.2980.587.0359view →
Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR4K7P–LUSC (OS)

Kaplan–Meier survival curve for OR4K7P RNA-high vs -low samples in LUSC.

Open the LUSC breakdown →

Exploration